|
Real-time Estimate
Cboe BZX
13:00:16 2026-08-17 EDT
|
5-day change | 1st Jan Change | ||
| 84.72 USD | +0.02% |
|
+0.68% | +82.01% |
| Market Cap | 8.98B 7.76B 7.28B 6.63B 12.46B 859B 12.63B 85.29B 33.42B 430B 33.73B 33B 1,432B | P/E 2026 * |
-18.2x | P/E 2027 * | -20.6x |
|---|---|---|---|---|---|
| Enterprise Value | 7.95B 6.86B 6.44B 5.86B 11.03B 760B 11.18B 75.47B 29.57B 381B 29.84B 29.2B 1,267B | EV / Sales 2026 * |
105x | EV / Sales 2027 * | 44.9x |
| Free-Float |
98.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Crinetics Pharmaceuticals, Inc.
| 1 day | +0.02% | ||
| 1 week | +0.68% | ||
| Current month | +1.44% | ||
| 1 month | +1.03% | ||
| 3 months | +144.16% | ||
| 6 months | +93.97% | ||
| Current year | +82.01% |
| 1 week | 84.2 |  | 84.74 |
| 1 month | 83.47 | | 84.74 |
| Current year | 32.3 | | 84.74 |
| 1 year | 28.73 | | 84.74 |
| 3 years | 15.76 | | 84.74 |
| 5 years | 15.23 | | 84.74 |
| 10 years | 10.63 | | 84.74 |
| Manager | Title | Age | Since |
|---|---|---|---|
R. Struthers
CEO | Chief Executive Officer | 64 | 2008-11-30 |
Stephen Betz
CTO | Chief Tech/Sci/R&D Officer | 60 | 2021-09-30 |
Tobin Schilke
DFI | Director of Finance/CFO | 51 | 2025-02-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Wendell Wierenga
CHM | Chairman | 78 | 2015-09-30 |
R. Struthers
BRD | Director/Board Member | 64 | 2008-10-31 |
Matthew Fust
BRD | Director/Board Member | 61 | 2018-01-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/7/26 | Fiscal year | Founder | 39,856 | 0.0378% | ||
| 7/2/26 | Sell | Director | -3,000 | 0.0028% | ||
| 3/12/26 | Sell | Director | 5,000 | 0.0048% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.02% | +0.68% | +184.89% | +422.67% | 8.98B | |
| +4.80% | +7.80% | +70.64% | +114.21% | 70.07B | |
| +17.12% | +11.50% | +49.15% | +87.30% | 52.87B | |
| +2.34% | -5.96% | -0.43% | +476.81% | 27.02B | |
| +2.26% | +0.65% | +49.19% | +10.30% | 23.61B | |
| -1.45% | -0.96% | -18.34% | -18.83% | 23.38B | |
| -6.00% | +13.71% | +244.39% | +443.26% | 19.43B | |
| +3.80% | +5.62% | +39.57% | -15.26% | 18.75B | |
| +0.38% | -3.15% | +20.39% | +589.77% | 15.85B | |
| +2.18% | -0.93% | +38.94% | +149.83% | 12.7B | |
| Average | +2.55% | -1.80% | +67.84% | +226.01% | 27.27B | |
| Weighted average by Cap. | +4.82% | -1.08% | +59.55% | +178.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 76.02M 65.63M 61.57M 56.08M 105M 7.27B 107M 722M 283M 3.64B 285M 279M 12.11B | 181M 156M 146M 133M 251M 17.27B 254M 1.72B 672M 8.65B 678M 664M 28.79B |
| Net income | -507M -438M -411M -374M -704M -48.52B -714M -4.82B -1.89B -24.31B -1.91B -1.86B -80.86B | -463M -400M -375M -342M -643M -44.31B -652M -4.4B -1.72B -22.2B -1.74B -1.7B -73.84B |
| Net Debt | -1.04B -894M -838M -764M -1.44B -98.96B -1.46B -9.83B -3.85B -49.58B -3.89B -3.8B -165B | -865M -747M -701M -638M -1.2B -82.72B -1.22B -8.21B -3.22B -41.44B -3.25B -3.18B -138B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-17 | US$84.73 | +0.03% | 425,475 |
| 26-08-14 | US$84.70 | +0.31% | 2,279,053 |
| 26-08-13 | US$84.44 | -0.02% | 1,289,231 |
| 26-08-12 | US$84.46 | +0.12% | 2,583,863 |
| 26-08-11 | US$84.36 | +0.25% | 1,422,042 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CRNX Stock
Select your edition
All financial news and data tailored to specific country editions
